Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Hyep Ivan. Officer active across 1 company, notably Bicara Therapeutics Inc.. Aggregated, 17 disclosures have been recorded. Split: 0 buy · 6 sells. Total volume traded: €1.4m. Activity tracked since 6 October 2025. The latest transaction was filed on 10 August 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Hyep Ivan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
12,500 shares@ US$3.7898Common StockSEC:0001470831-26-000814:0
12,500 shares@ US$27.9673Common StockSEC:0001470831-26-000814:1
12,500 shares@ US$3.78980.0025% mcap2.0% of flowCommon StockSEC:0001470831-26-000700:0
22,757 shares@ US$28.6020.034% mcap28.1% of flowCommon StockSEC:0001470831-26-000700:1
4,413 shares@ US$29.82460.0070% mcap5.7% of flowCommon StockSEC:0001470831-26-000700:2
830 shares@ US$30.31360.0013% mcap1.1% of flowCommon StockSEC:0001470831-26-000700:3
9,200 shares@ US$3.789815.7% of flowCommon StockSEC:0001628280-26-038248:0
9,200 shares@ US$20.422184.3% of flowCommon StockSEC:0001628280-26-038248:1
9,200 shares@ US$3.78980.0018% mcap7.4% of flowCommon StockSEC:0001628280-26-026604:0
9,200 shares@ US$23.00150.011% mcap44.9% of flowCommon StockSEC:0001628280-26-026604:1
9,200 shares@ US$3.78987.0% of flowCommon StockSEC:0001628280-26-020876:0
7,318 shares@ US$3.78981.9% of flowCommon StockSEC:0001628280-26-015421:0
1,882 shares@ US$3.78980.3% of flowCommon StockSEC:0001628280-26-003418:0
9,200 shares@ US$3.78982.4% of flowCommon StockSEC:0002034668-25-000012:0
605 shares@ US$3.78980.2% of flowCommon StockSEC:0002034668-25-000010:0
6,415 shares@ US$3.78981.7% of flowCommon StockSEC:0002034668-25-000007:0
6,514 shares@ US$3.78981.7% of flowCommon StockSEC:0002034668-25-000004:0
About Hyep Ivan
Hyep Ivan is a declarant associated with Bicara Therapeutics Inc. (XNAS), where the listed role is Chief Financial Officer. He has 15 filings in total, and across the recent sample of 15 filings, the recorded transactions run from 2025-10-08 to 2026-07-10, with EUR 0 of buys and EUR 1050106 of sells, and the modal transaction nature is Levée d'options.